$17.24
-0.58-3.25%
Last update: Nov 10, 7:42 AM
Sarepta Therapeutics Inc
SRPTNASDAQ
The average analyst price target for Sarepta Therapeutics is $24.56, 39.9% above the current price. Of 24 analysts, 9 rate it Buy, 10 Hold and 5 Sell. Targets range from $5 to $80. The latest change came on Nov 6, 2026, when RBC Capital raised its price target on Sarepta Therapeutics from $17 to $18 and kept a Sector Perform rating.
Price Target Range — 7 Quarters
Analyst Consensus — 24 Analysts
Rating Trend — Last 9 Months
